NCT03481920 A Trial of PEGPH20 in Combination With Avelumab in Chemotherapy Resistant Pancreatic Cancer Status TERMINATED Phase EARLY_PHASE1
NCT03475966 Improving Outcomes in Cancer Patients With a Nutritional and Physical Conditioning Prehabilitation Program Status UNKNOWN Phase NA
NCT03471468 Kinetics of Microparticles Under Chemotherapy in Patients With Gastric or Pancreatic Cancer Status TERMINATED Phase NA
NCT03469375 Modified-FOLFIRINOX Regimen Based Neoadjuvant Therapy in Chinese Patients With Locally Advanced Pancreatic Cancer Status COMPLETED Phase N/A
NCT03469258 Study of Pancreatic Enzyme Replacement on Completion of Adjuvant Chemotherapy for Resected Pancreatic Adenocarcinoma Status TERMINATED Phase PHASE2
NCT03460769 Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) Status RECRUITING Phase N/A
NCT03454451 CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers Status COMPLETED Phase PHASE1
NCT03454035 Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors Status RECRUITING Phase PHASE1
NCT03451773 M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas Status TERMINATED Phase PHASE1/PHASE2
NCT03435770 Evaluation of Safety and Feasibility of EUS-guided RFA for Solid Pancreatic Neoplasms Status UNKNOWN Phase NA
NCT03435289 A Study of CPI-613 With Gemcitabine and Nab-paclitaxel for Patients With Advanced or Metastatic Pancreatic Cancer Status UNKNOWN Phase PHASE1
NCT03434678 Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection Status COMPLETED Phase PHASE3
NCT03417843 Safety and Efficacy of an Ablation Catheter for the Treatment of Pancreatic Premalignant Cyctic Lesions. Status UNKNOWN Phase NA
NCT03415854 Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) Status COMPLETED Phase PHASE2
NCT03410030 Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM) Status COMPLETED Phase PHASE1/PHASE2
NCT03407040 Generation of Cancer Antigen-Specific T-cells From Human Induced Pluripotent Stem Cells (iPSC) for Research and Potential FutureTherapy Status TERMINATED Phase N/A